Together, these findings suggest that MEG3, HOTAIRM1, HAND2-AS1, and ADAMTS9-AS2 may form a co-regulated epigenetic network involved in the modulation of signaling pathways that drive BC progression. The gene discussed is MEG3; the disease is breast cancer.